SEC Tracker
Get the app

Bausch Health Companies BHC

Bausch Health Companies reports share changes

Sandra Leung, insider filing for BHC

Form
4
Filed
Importance
Routine
  1. Sandra Leung acquired 5,789 shares on Sep 30, 2026
  2. Shares beneficially owned: 102,859
  3. Restricted Share Units issued for board service

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Bausch Health Companies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Recursion Pharmaceuticals RXRX public float $2.0B, Jun 30, 2025
  2. Agios Pharmaceuticals AGIO public float $1.9B, Jun 30, 2025
  3. Vericel VCEL public float $2.1B, Jun 30, 2025
  4. Biocryst Pharmaceuticals BCRX public float $1.9B, Jun 30, 2025
  5. Indivior Pharmaceuticals INDV public float $1.8B, Jun 30, 2025